Skip to main content

Table 2 Comparison of quality indicators of end-of-life cancer care in the last month

From: Effect of hospice care on quality indicators of end-of-life care among patients with liver cancer: a national longitudinal population-based study in Taiwan 2000–2011

Variables Total Non-H group Short-H group Long-H group p-value p-value for trend test
N (%) 3092(100 %) 2630(85.1 %) 325(10.5 %) 137(4.4 %)   
ICU admission 580(18.8 %) 548(20.8 %) 22(6.8 %) 10(7.3 %) <0.001 <0.001
CPR 613(19.8 %) 595(22.6 %) 9(2.8 %) 9(6.6 %) <0.001 <0.001
More than one ER visit 153(4.9 %) 120(4.6 %) 29(8.9 %) 4(2.9 %) 0.003 0.217
More than one admission(>1) 695(22.5 %) 556(21.1 %) 103(31.7 %) 36(26.3 %) <0.001 <0.001
Death in acute care wards 1182(38.2 %) 1182(44.9 %) 0 0 - -
Death in hospice ward 302(9.8 %) 0 221(68.0 %) 81(59.1 %) - -
Anti-cancer therapy       
 Chemotherapy 61(2.0 %) 49(1.9 %) 9(2.8 %) 3(2.2 %) 0.459 0.406
 TACE 128(4.1 %) 117(4.4 %) 7(2.2 %) 4(2.9 %) 0.117 0.074
 HAIC 37(1.2 %) 30(1.1 %) 6(1.8 %) 1(0.7 %) 0.496 0.781
 PEI 10(0.3 %) 10(0.4 %) 0 0 0.755 0.215
 RFA 11(0.4 %) 11(0.4 %) 0 0 0.771 0.193
 Radiotherapy 157(5.1 %) 119(4.5 %) 25(7.7 %) 13(9.5 %) 0.004 0.001
Ever anti-cancer therapy 348(11.3 %) 288(11.0 %) 41(12.6 %) 19(13.9 %) 0.362 0.183
  1. Abbreviations: Non-H group, patients who did not receive hospice care; Long-H group, patients who received hospice care for longer than 1 month; Short-H group, patients who received hospice care for a period shorter than 1 month; ICU, intensive care unit; CPR, cardiopulmonary resuscitation; ER, emergency room; TACE, transarterial chemoembolizations; HAIC, hepatic arterial infusion chemotherapy; PEI, percutaneous ethanol injection; RFA: radiofrequency ablation